Log Type Authored on Log Message Log Node Authored by
Newsletter sent Newsletter sent to:seedseed3013@yahoo.co.jp Анонимен
Newsletter sent Newsletter sent to:ayam@lundbeck.com Анонимен
Newsletter sent Newsletter sent to:tata@lundbeck.com Анонимен
Newsletter sent Newsletter sent to:murayay@toyaku.ac.jp Анонимен
Newsletter sent Newsletter sent to:debapriya.paul@iqvia.com Анонимен
Newsletter sent Newsletter sent to:HIHS@lundbeck.com Анонимен
Newsletter sent Newsletter sent to:Jukn@lundbeck.com Анонимен
Newsletter sent Newsletter sent to:KUMU@lundbeck.com Анонимен
Newsletter sent Newsletter sent to:NASU@lundbeck.com Анонимен
Newsletter sent Newsletter sent to:SAAW@lundbeck.com Анонимен
Newsletter sent Newsletter sent to:fugo@lundbeck.com Анонимен
Newsletter sent Newsletter sent to:YUMT@lundbeck.com Анонимен
Newsletter sent Newsletter sent to:tahi@lundbeck.com Анонимен
Newsletter sent Newsletter sent to:yatk@lundbeck.com Анонимен
Newsletter sent Newsletter sent to:PDase@in.imshealth.com Анонимен
Newsletter sent Newsletter sent to:saipriyadarshini.j@in.imshealth.com Анонимен
Newsletter sent Newsletter sent to:GDM@Lundbeck.com Анонимен
Newsletter sending Sending to 69 Анонимен
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Newsletter clicked Clicked https://japan.progress.im/ja/content/%E5%8F%8C%E6%A5%B5%E6%80%A7%E9%9A%9C%E5%AE%B3%E3%81%AB%E3%81%8A%E3%81%91%E3%82%8B%E8%AA%8D%E7%9F%A5%E6%A9%9F%E8%83%BD%E9%9A%9C%E5%AE%B3%E3%81%AE%E6%A0%B9%E5%BA%95%E3%81%AB%E3%81%82%E3%82%8B%E3%82%82%E3%81%AE%E3%81 Анонимен
Newsletter opened Opened Анонимен
Newsletter clicked Clicked https://japan.progress.im/ja/content/covid-19%E3%83%91%E3%83%B3%E3%83%87%E3%83%9F%E3%83%83%E3%82%AF%E4%B8%AD%E3%81%AB%E5%A6%8A%E5%A9%A6%E3%81%8A%E3%82%88%E3%81%B3%E7%94%A3%E5%BE%8C%E3%81%AE%E5%A5%B3%E6%80%A7%E3%81%A7%E6%8A%91%E3%81%86%E3%81%A4%E3%81% Анонимен
Log Type Authored on Log Message Log Node Authored by
Newsletter sent Newsletter sent to:seedseed3013@yahoo.co.jp Анонимен
Newsletter sent Newsletter sent to:ayam@lundbeck.com Анонимен
Newsletter sent Newsletter sent to:tata@lundbeck.com Анонимен
Newsletter sent Newsletter sent to:murayay@toyaku.ac.jp Анонимен
Newsletter sent Newsletter sent to:debapriya.paul@iqvia.com Анонимен
Newsletter sent Newsletter sent to:HIHS@lundbeck.com Анонимен
Newsletter sent Newsletter sent to:Jukn@lundbeck.com Анонимен
Newsletter sent Newsletter sent to:KUMU@lundbeck.com Анонимен
Newsletter sent Newsletter sent to:NASU@lundbeck.com Анонимен
Newsletter sent Newsletter sent to:SAAW@lundbeck.com Анонимен
Newsletter sent Newsletter sent to:fugo@lundbeck.com Анонимен
Newsletter sent Newsletter sent to:YUMT@lundbeck.com Анонимен
Newsletter sent Newsletter sent to:tahi@lundbeck.com Анонимен
Newsletter sent Newsletter sent to:yatk@lundbeck.com Анонимен
Newsletter sent Newsletter sent to:PDase@in.imshealth.com Анонимен
Newsletter sent Newsletter sent to:saipriyadarshini.j@in.imshealth.com Анонимен
Newsletter sent Newsletter sent to:GDM@Lundbeck.com Анонимен
Newsletter sending Sending to 69 Анонимен
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Newsletter clicked Clicked https://japan.progress.im/ja/content/%E5%8F%8C%E6%A5%B5%E6%80%A7%E9%9A%9C%E5%AE%B3%E3%81%AB%E3%81%8A%E3%81%91%E3%82%8B%E8%AA%8D%E7%9F%A5%E6%A9%9F%E8%83%BD%E9%9A%9C%E5%AE%B3%E3%81%AE%E6%A0%B9%E5%BA%95%E3%81%AB%E3%81%82%E3%82%8B%E3%82%82%E3%81%AE%E3%81 Анонимен
Newsletter opened Opened Анонимен
Newsletter clicked Clicked https://japan.progress.im/ja/content/covid-19%E3%83%91%E3%83%B3%E3%83%87%E3%83%9F%E3%83%83%E3%82%AF%E4%B8%AD%E3%81%AB%E5%A6%8A%E5%A9%A6%E3%81%8A%E3%82%88%E3%81%B3%E7%94%A3%E5%BE%8C%E3%81%AE%E5%A5%B3%E6%80%A7%E3%81%A7%E6%8A%91%E3%81%86%E3%81%A4%E3%81% Анонимен